Department of Renal Medicine, Danderyd Hospital, Stockholm, Sweden.
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Kidney Blood Press Res. 2021;46(2):250-256. doi: 10.1159/000514268. Epub 2021 Mar 26.
The COVID-19 outbreak has been associated with a high morbidity, mortality, and a risk of long-term sequelae, and patients with severe COVID-19 are at increased risk of acute kidney injury. CKD patients are at high risk of being exposed to COVID-19 and suffer complications and poor outcome. In Sweden, mitigation strategies did not include lockdown. During March-April of 2020, wide-spread infection occurred in Stockholm.
Management and outcomes in forty hemodialysis (HD) patients and 4 peritoneal dialysis (PD) patients, with symptomatic COVID-19 in greater Stockholm during March and April of 2020 are reported.
Twenty-four HD patients (60%) required medical care and hospitalization, whereas 16 patients (40%) were treated at home. Nine patients died (mortality rate of 22.5%), of whom 8 were men. The median age in non-survivors (78 years) was significantly higher than in survivors (p = 0.003). The median time in dialysis (11.5 years) was also significantly longer in non-survivors (p = 0.01). C-reactive protein (CRP) at diagnosis in 7 of non-survivors (median 213 mg/L, range 86-329 mg/L) was significantly higher than the CRP in 25 survivors (median 87 mg/L, range 1-328 mg/L) (p = 0.0003). Maximum CRP also indicated poorer outcome among hospitalized patients (p = 0.0004). The gender imbalance was striking with only men dying apart from 1 elderly woman. Only 4 PD patients were hospitalized with symptomatic COVID-19. One patient died, 2 were discharged, and 1 was treated at the intensive care unit and survived.
HD patients >70 years were reported with longer dialysis vintage, higher CRP, and males were at an increased risk of dying from COVID-19, whereas those <70 years seemed to have a milder disease. Mitigation strategies to reduce rates of infection in high-risk populations remain essential. Follow-up focusing on long-term prognosis for extrapulmonary manifestations is likely to be important also in dialysis patients.
COVID-19 疫情发病率、死亡率高,并存在长期后遗症风险,重症 COVID-19 患者发生急性肾损伤的风险增加。CKD 患者感染 COVID-19 风险高,并发症多,预后不良。瑞典未采取封锁等缓解策略。2020 年 3-4 月,斯德哥尔摩广泛传播感染。
报告了 2020 年 3-4 月斯德哥尔摩地区症状性 COVID-19 的 40 名血液透析(HD)患者和 4 名腹膜透析(PD)患者的管理和结局。
24 名 HD 患者(60%)需要医疗和住院治疗,16 名患者(40%)在家治疗。9 名患者死亡(死亡率 22.5%),其中 8 名男性。非幸存者(78 岁)的中位年龄明显高于幸存者(p = 0.003)。非幸存者的中位透析时间(11.5 年)也明显长于幸存者(p = 0.01)。7 名非幸存者(中位数 213mg/L,范围 86-329mg/L)的 C 反应蛋白(CRP)在诊断时明显高于 25 名幸存者(中位数 87mg/L,范围 1-328mg/L)(p = 0.0003)。住院患者的 CRP 最大值也表明预后较差(p = 0.0004)。性别失衡显著,除了一名老年妇女外,只有男性死亡。仅有 4 名 PD 患者因症状性 COVID-19 住院。1 名患者死亡,2 名患者出院,1 名患者在重症监护病房接受治疗并存活。
报告了年龄>70 岁的 HD 患者,透析时间较长,CRP 较高,男性感染 COVID-19 死亡风险增加,而年龄<70 岁的患者疾病似乎较轻。减少高危人群感染率的缓解策略仍然至关重要。关注透析患者肺外表现的长期预后可能也很重要。